Topic: Ovarian Cancer
Over 45 years of age in women not given birth, if frequent stomach pain, bloating, and after treatment did not improve, they should pay attention, this may be early signs of ovarian cancer. Experts pointed out that the Qi Cheng ovarian cancer ...
WASHINGTON (Reuters) - An experimental test that uses antibodies to detect ovarian tumor cells in the blood correctly identified 16 of 17 women who had the cancer, a Belgian company said on Tuesday. MabCure Inc said its monoclonal antibodies threw up no ...
CHICAGO (Reuters) - About 48 percent of women with advanced ovarian cancer saw sustained benefits from treatment with Nektar Therapeutics' experimental drug NKTR-102 in a mid-stage study, the company said on Sunday. Twenty-three percent of patients on a dose schedule of once ...
A new screening approach to detect early stage ovarian cancer in post-menopausal women has proven promising, researchers said of results to a study released Thursday. "More than 70 percent of ovarian cancers are diagnosed when they have already grown to an advanced ...
CHICAGO (Reuters) - Researchers have found a new way to use an existing blood test that may provide a way to screen women for ovarian cancer, perhaps in time to cure more women of the deadly disease. They said combining a test ...
Doctors may be getting closer to having a way to screen healthy women for signs of ovarian cancer, one of the deadliest forms of cancer. The method uses a blood test for a protein that often is high in women with ovarian ...
NEW YORK (Reuters Health) - Women who eat a lot of processed meats, such as salami and hot dogs, are at a higher risk of ovarian cancer, according to a new Australian study. At the same time, those who eat a lot ...
LONDON (Reuters) - An experimental drug from AstraZeneca that blocks a cell repair enzyme known as PARP has shown promise as a treatment for ovarian cancer, as well as breast cancer, researchers said on Monday. Olaparib shrank or stabilized tumors in around ...
Quest Diagnostics selling presurgical ovarian cancer test, cites improved treatment potentialMedical lab operator Quest Diagnostics Inc. said Monday it is selling the OVA1 blood test, which aims to better assess a woman's likelihood for ovarian cancer. The OVA1 test, which was approved ...
NEW YORK (Reuters Health) - Only one in 100 women with symptoms typical of ovarian cancer, such as persistent bloating or pelvic pain, actually has the disease, researchers reported on Thursday. Several medical societies recommend the use of these and other symptoms ...